The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
Background: Interactive and mobile technology to manage alcohol use problem potentially provide continuing care by offering emotional and instrumental support anywhere and in time, but the effectiveness for maintaining abstinence has not been examined. the investigators will evaluate in this study whether the smartphone-based support system would improve outcomes for people in recovery for alcohol dependence. To enable continuous self-monitoring and self-management, the phone support system prompts subjects to take Breath Alcohol Concentration (BrAC) tests using a phone application and a Bluetooth sensor unit. The system also offers instantaneous feedback, self-management strategies, and anonymous mutual social support from other subjects.
Methods: This three-year project will be conducted in three stages, including pilot study, efficacy evaluation (12 week), and post-intervention follow-up (12 week) stage. Participants will be given a smartphone (if the subject does not have one), breathalyzer and training session. In the pilot study stage,10 subjects will be enrolled to validate the system. In the efficacy evaluation stage, the investigators will conduct a 12-week by enrolling 100 post-detoxification alcohol dependent patients who are randomized to (1) standard treatment (ST) group or (2) standard treatment plus phone-based support group (technology intervention, TI group). Participants will be assessed by Time-Line Follow-Back (TLFB) to record the frequency and quantity of alcohol consumption, visual analogue for craving, Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI), Satisfaction with Life Scale (SWLS), and Quality of life Scale (WHOQOL-BREF) and compared for outcome measures. After the 12-week trial, the investigators will take back the support system and follow the all subjects in both groups for another 12 weeks, i.e. post-intervention stage, to further understand the sustaining benefit from intervention. In addition, the investigators will identify the clinical variables or system factors that are associated with outcome measures.
Expected results: In this study, the investigators expect that in treatment-seeking alcohol dependent patients, a smartphone-supported self-management program, adding on to conventional treatment, will be beneficial in improving the drinking outcomes such as a higher abstinence rate, a lower relapse rate, and a lower drinking frequency and quantity.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Taipei, Taiwan, 110
- Werving
- Ming-Chyi
-
Contact:
- Ming-Chyi Huang, M.D., Ph.D
- Telefoonnummer: 1219 886-2-27263141
- E-mail: mch@tpech.gov.tw
-
Contact:
- Galen Hung, M.D.
- Telefoonnummer: 1305 886-2-27263141
- E-mail: galenhung@gmail.com
-
Hoofdonderzoeker:
- Ming-Chyi Huang, M.D., Ph.D.
-
Onderonderzoeker:
- Chuan-Wen Yu, Ph.D
-
Onderonderzoeker:
- Hao-Hua Chu, Ph.D
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Age between 20 and 50 years;
- Use an Android phone as his/her primary phone, or be willing to use an Android phone provided by National Taiwan University as his/her primary phone during the study;
- Fulfilling the Diagnostic and Statistical Manual version IV (DSM-IV) criteria of alcohol dependence assessed by the Structured Clinical Interview;
- Complete abstinence for at least 10 days and free of any withdrawal symptoms; and
- Drug screening test results negative opiates, amphetamines, and ketamine.
Exclusion Criteria:
- A current DSM-IV diagnosis of dependence or abuse on other substances except nicotine or the use of one to two low-potency benzodiazepine tablets for sleep impairment;
- A current mental or psychiatric impairment or disease that required psychotropic medication or inpatient treatment on a psychiatric ward;
- A history of opioid or psychostimulant abuse;
- A history of psychosis, including schizophrenia, bipolar I or bipolar II disorder, and major depressive disorder with psychotic features;
- Current use of any antipsychotics;
- Homelessness;
- Pregnancy, nursing, or refusal to use a reliable method of birth control in women;
- Cognitive deficit and not thus being able to comprehend the informed consent and study procedure
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Intervention group
This group of subjects receives mobile support system and conventional treatment
|
|
|
Geen tussenkomst: Control group
This group of patients receive conventional treatment only
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Time to first lapse
Tijdsspanne: 12 weeks
|
12 weeks
|
|
|
Time to first relapse
Tijdsspanne: 12 weeks
|
12 weeks
|
|
|
Cumulative abstinence days
Tijdsspanne: 12 weeks
|
12 weeks
|
|
|
Number of drinks per drinking days
Tijdsspanne: 12 weeks
|
each visit during the 12 weeks: week 1, 2, 4, 8, 12
|
12 weeks
|
|
VAS craving measurement
Tijdsspanne: 12 weeks
|
each visit during the 12 weeks: week 1, 2, 4, 8, 12
|
12 weeks
|
|
complete abstinence rate
Tijdsspanne: 12 weeks
|
12 weeks
|
|
|
Drop-out rate
Tijdsspanne: 12 weeks
|
each visit during the 12 weeks: week 1, 2, 4, 8, 12
|
12 weeks
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Ming-Chyi Huang, MD, PhD, Taipei City Psychiatric Center
- Studie stoel: Hao-Hua Chu, PhD, Department of Computer Science and Information Engineering, National Taiwan University
- Studie directeur: Chuang-Wen You, PhD, Intel-NTU Connected Context Computing Center, National Taiwan University
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- MOST 103-2628-B-532 -001 -MY3
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .